What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
International Psoriasis Council

Welcome and Introduction
André Vicente Esteves de Carvalho
COVID-19 and psoriasis
Peter van de Kerkhof
Challenging Case: Linfoma después del tratamiento biológico: ¿Qué fue primero?
Angela Londoño
Challenging Case: Paradoxical psoriasis induced by anti-TNF
Romina Contreras
Challenging Case: To be or not to be? It is not always psoriasis.
Fernando Valenzuela
Challenging Case: Eventos adversos cutáneos durante la terapia biológica.
André Vicente Esteves de Carvalho
Faculty Discussion
All faculty
Closing
Angela Londoño
All RADLA 2021 Videos